| MKVCX | TRTIX | MKVCX / TRTIX | |
| Total Expense Ratio | 1.71 | 0.68 | 251% |
| Annual Report Gross Expense Ratio | 1.74 | 0.68 | 256% |
| Fund Existence | 6 years | 11 years | - |
| Gain YTD | 11.423 | 12.962 | 88% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 500000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.31B | 17B | 43% |
| Annual Yield % from dividends | 2.47 | 2.52 | 98% |
| Returns for 1 year | 20.82 | 28.51 | 73% |
| Returns for 3 years | 52.04 | 83.95 | 62% |
| Returns for 5 years | 53.54 | 94.24 | 57% |
| Returns for 10 years | N/A | 158.80 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RSMVX | 13.52 | N/A | N/A |
| William Blair Small-Mid Cap Value R6 | |||
| PAGRX | 158.19 | N/A | N/A |
| Permanent Portfolio Aggressive Growth I | |||
| PNBAX | 30.86 | N/A | N/A |
| Virtus NFJ Large-Cap Value A | |||
| BDHCX | 9.06 | N/A | N/A |
| BlackRock Dynamic High Income Inv C | |||
| JNGLX | 88.37 | -0.69 | -0.77% |
| Janus Henderson Global Life Sciences D | |||